Peripheral blood counts | Biochemistry | Serology |
WBC | 11,100/µL | TP | 7.8 g/dL | CRP | 4.48 mg/dL |
Neut | 54.6% | Alb | 3.1 g/dL | HBsAg | (−) |
RBC | 492 × 104/µL | T-bil | 0.7 mg/dL | HCVAb | (−) |
Hb | 14.4 g/dL | D-bil | 0.1 mg/dL | Tumour markers |
Hct | 42.4% | AST | 24 U/I | AFP | 2.9 ng/dL |
Plt | 36.1 × 104/µL | ALT | 14 U/I | CEA | 6.3 ng/mL |
Coagulation | ALP | 987 U/I | CA19-9 | 69.4 U/mL |
PT | 83.2% | γ-GTP | 264 U/I | Others |
APTT | 31 s | BUN | 12 mg/dL | ELISA | (±) |
Fibrinogen | 448 mg/dL | Cr | 0.5 mg/dL | WB | (+) |
d-dimer | 0.85 µg/mL | | |
- WBC, white blood cells; Neut, neutrophils; RBC, red blood cells; Hb, haemoglobin; Hct, haematocrit; Plt, platelet count; PT, prothrombin time; APTT, activated partial thromboplastin time; TP, total protein; Alb, serum albumin; T-bil, total bilirubin; D-bil, direct bilirubin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; γ-GTP, gamma-glutamyl transpeptidase; BUN, blood urea nitrogen; Cr, creatinine; CRP, C-reactive protein; HBsAg, hepatitis B virus surface antigen; HCV Ab, hepatitis C virus antibody; AFP, alpha-fetoprotein; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9; ELISA, enzyme-linked immunosorbent assay; WB, Western blotting
